Stay updated on Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck SCC
Sign up to get notified when there's something new on the Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck SCC page.

Latest updates to the Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck SCC page
- Check4 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden error, replacing the usual content with an error screen. The additions include the 403 message and a basic header, signaling an access restriction rather than substantive content changes.SummaryDifference18%

- Check11 days agoChange DetectedAdded Tel Litwinsky, Israel, 52621 as a participating site and removed Qiryat Krinitzi, Israel, 52621 from the participating sites.SummaryDifference0.0%

- Check18 days agoChange DetectedIsrael enrollment sites were updated by removing Tel Litwinsky and adding Qiryat Krinitzi (postal code 52621). This reflects a change in the locations where participants can enroll and the study is conducted in that region.SummaryDifference0.0%

- Check25 days agoChange DetectedThe page revision tag was updated to v3.6.6. The previous revision tag v3.6.5 was removed.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a minor patch to the page's platform. No study content or user-facing information is altered.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page revision tag changed from v3.6.3 to v3.6.4, indicating a small update to the page version. This update does not modify study details or visible content.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck SCC
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck SCC page.